South Korea’s Samsung Biologics said on Monday that it had made an all-cash bid of 1.46 billion Swiss francs ($1.8 billion) for Switzerland’s PolyPeptide Group.
原文: https://www.cnbc.com/2026/07/20/samsung-biologics-polypeptide-group-deal-switzerland.html
Last Update:
20 7 月, 2026
